Topics

Peficitinib reduces rheumatoid arthritis symptoms in latest trial

02:00 EDT 13 Sep 2019 | Arthritis Digest

A new rheumatoid arthritis JAK inhibitor called peficitinib has fared well in new trials, scientists outline in Annals of the Rheumatic Diseases. A total of 507 people with rheumatoid arthritis and an inadequate response to disease-modifying anti-rheumatic drugs (DMARDs) were split into groups for 52 weeks: peficitinib 100mg once daily; peficitinib 150mg once daily; placebo […]

The post Peficitinib reduces rheumatoid arthritis symptoms in latest trial appeared first on Arthritis Digest.

Original Article: Peficitinib reduces rheumatoid arthritis symptoms in latest trial

NEXT ARTICLE

More From BioPortfolio on "Peficitinib reduces rheumatoid arthritis symptoms in latest trial"

Quick Search

Relevant Topic

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...